Prostate cancer gene hunt could spot relapse early
NCT ID NCT03421015
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at genetic changes in prostate cancer samples from 84 men who had surgery. The goal was to find DNA markers that could predict if the cancer would come back or spread. By identifying these markers, doctors may one day better tailor follow-up care and treatment for high-risk patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Claude Huriez, CHRU
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill slow advanced prostate cancer?
- Immunotherapy combo takes on Hard-to-Treat prostate cancer
- Could a targeted drug delay prostate cancer progression?
- Prostate cancer treatment may change how men process common sleep aid
- Can a simple WhatsApp message save lives? chile tests new screening nudge
- New hope for hard-to-treat cancers? experimental combo enters phase 2 trial